Literature DB >> 19296224

Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.

Anand Patel1, Moin Modasiya, Dushyant Shah, Vishnu Patel.   

Abstract

A novel gastro retentive controlled release drug delivery system of verapamil HCl was formulated in an effort to increase the gastric retention time of the dosage form and to control drug release. Hydroxypropylmethylcellulose (HPMC), carbopol, and xanthan gum were incorporated for gel-forming properties. Buoyancy was achieved by adding an effervescent mixture of sodium bicarbonate and anhydrous citric acid. In vitro drug release studies were performed, and drug release kinetics was evaluated using the linear regression method. The optimized intragastric floating tablet composed of 3:2 of HPMC K4M to xanthan gum exhibited 95.39% drug release in 24 h in vitro, while the buoyancy lag time was 36.2 s, and the intragastric floating tablet remained buoyant for >24 h. Zero-order and non-Fickian release transport was confirmed as the drug release mechanism from the optimized formulation (F7). X-ray studies showed that total buoyancy time was able to delay the gastric emptying of verapamil HCl intragastric floating tablet in mongrel dogs for more than 4 h. Optimized intragastric floating tablet showed no significant change in physical appearance, drug content, total buoyancy time, or in vitro dissolution pattern after storage at 40 degrees C/75% relative humidity for 3 months.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296224      PMCID: PMC2663699          DOI: 10.1208/s12249-009-9210-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

1.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

2.  Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.

Authors:  Brijesh S Dave; Avani F Amin; Madhabhai M Patel
Journal:  AAPS PharmSciTech       Date:  2004-04-08       Impact factor: 3.246

3.  The macromolecular polymers for the preparation of hydrodynamically balanced systems--methods of evaluation.

Authors:  P Dorozyński; R Jachowicz; P Kulinowski; S Kwieciński; K Szybiński; T Skórka; A Jasiński
Journal:  Drug Dev Ind Pharm       Date:  2004       Impact factor: 3.225

Review 4.  Gastroretentive drug delivery systems.

Authors:  Alexander Streubel; Juergen Siepmann; Roland Bodmeier
Journal:  Expert Opin Drug Deliv       Date:  2006-03       Impact factor: 6.648

5.  Design and evaluation of bilayer floating tablets of captopril.

Authors:  Ziyaur Rahman; Mushir Ali; Rk Khar
Journal:  Acta Pharm       Date:  2006-03       Impact factor: 2.230

6.  The effect of density on the gastric emptying of single- and multiple-unit dosage forms.

Authors:  S S Davis; A F Stockwell; M J Taylor; J G Hardy; D R Whalley; C G Wilson; H Bechgaard; F N Christensen
Journal:  Pharm Res       Date:  1986-08       Impact factor: 4.200

7.  Development of a novel controlled-release system for gastric retention.

Authors:  A A Deshpande; N H Shah; C T Rhodes; W Malick
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

8.  Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers.

Authors:  J A Fix; R Cargill; K Engle
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

Review 9.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

10.  Floating hot-melt extruded tablets for gastroretentive controlled drug release system.

Authors:  Mamoru Fukuda; Nicholas A Peppas; James W McGinity
Journal:  J Control Release       Date:  2006-07-21       Impact factor: 9.776

View more
  8 in total

1.  Features and Facts of a Gastroretentive Drug Delivery System-A Review.

Authors:  Kuldeep Vinchurkar; Jitendra Sainy; Masheer Ahmed Khan; Sheetal Mane; Dinesh K Mishra; Pankaj Dixit
Journal:  Turk J Pharm Sci       Date:  2022-08-31

Review 2.  Citric Acid: A Multifunctional Pharmaceutical Excipient.

Authors:  Maria Lambros; Thac Henry Tran; Qinqin Fei; Mike Nicolaou
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

3.  Sustained-release effervescent floating matrix tablets of baclofen: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.

Authors:  S Gande; Ym Rao
Journal:  Daru       Date:  2011       Impact factor: 3.117

Review 4.  Role of excipients and polymeric advancements in preparation of floating drug delivery systems.

Authors:  Avinash Y Kaushik; Ajay K Tiwari; Ajay Gaur
Journal:  Int J Pharm Investig       Date:  2015 Jan-Mar

5.  Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of in-vivo plasma profiles.

Authors:  Soha M El-Masry; Sally A Helmy
Journal:  Saudi Pharm J       Date:  2020-11-06       Impact factor: 4.330

6.  In Vitro and In Vivo Studies of a Verapamil-Containing Gastroretentive Solid Foam Capsule.

Authors:  Ádám Haimhoffer; Gábor Vasvári; István Budai; Monika Béresová; Ádám Deák; Norbert Németh; Judit Váradi; Dávid Sinka; Ildikó Bácskay; Miklós Vecsernyés; Ferenc Fenyvesi
Journal:  Pharmaceutics       Date:  2022-02-02       Impact factor: 6.321

7.  FDM 3D-Printed Sustained-Release Gastric-Floating Verapamil Hydrochloride Formulations with Cylinder, Capsule and Hemisphere Shapes, and Low Infill Percentage.

Authors:  Haonan Qian; Di Chen; Xiangyu Xu; Rui Li; Guangrong Yan; Tianyuan Fan
Journal:  Pharmaceutics       Date:  2022-01-25       Impact factor: 6.321

8.  Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.

Authors:  Mohamed A El Nabarawi; Mahmoud H Teaima; Rehab A Abd El-Monem; Nagla A El Nabarawy; Dalia A Gaber
Journal:  Drug Des Devel Ther       Date:  2017-04-03       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.